Skip to main content

Sterile Filtration Market by Product, Application & End User – 2020

The report “Sterile Filtration Market by Product (Membrane Filters, Cartridges & Capsules, Syringe Filters), Application (Bioprocesses, Fill-finish process, Utilities Filtration, Pre-Filtration), Membrane Pore Size (0.22 Microns), End-User – Global Forecast to 2020″, report provides a detailed overview of the major drivers, restraints, opportunities, challenges and trends impacting the global sterile filtration market along with the estimates and forecasts of the revenue and market share analysis.

Browse 83 market data Tables and 111 Figures spread through 193 Pages and in-depth TOC on “Sterile Filtration Market by Product (Membrane Filters, Cartridges & Capsules, Syringe Filters), Application (Bioprocesses, Fill-finish process, Utilities Filtration, Pre-Filtration), Membrane Pore Size (0.22 Microns), End-User – Global Forecast to 2020”
http://www.marketsandmarkets.com/Market-Reports/sterile-filtration-market-256410424.html
Early buyers will receive 10% customization on reports.

The global sterile filtration market is expected to reach USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4% from 2015 to 2020. Increase in R&D spending, growth in the biopharmaceutical industry, growing demand for biopharmaceutical molecules, rising incidence of diabetes & kidney failure, and increasing purity requirement in end-users, are the primary growth drivers for this market during the forecast period (2015–2020). However, stringent government regulations for validation of filtration process may hinder the growth of this market.

The global sterile filtration market is segmented on the basis of products, applications, membrane pore size, and end-user. On the basis of product, the market is segmented into membrane filters, cartridges & capsules, syringe filters, bottle-top vacuum filters, filter funnels & holders, and filtration accessories. Of these, the membrane filters product segment accounted for the largest share of the global sterile filtration market in 2015, large share of this segment can primarily be attributed to the increasing use of membrane filters for various filtration applications and higher frequency of purchase of these filters as compared to cartridges & capsules, syringe filters, and bottle-top vacuum filters. On the basis of end-user, the market is segmented into pharmaceutical & biotechnology companies, academic institutes & research laboratories, food & beverage industry, and water filtration companies. Of these, the pharmaceutical & biotechnology end-user segment accounted for the largest share of the global sterile filtration market in 2015, large share of this segment is due to the utilization of sterile filtration techniques for meeting filtration and separation requirements from R&D activities to early-stage product development to full-scale manufacturing in the pharmaceutical & biotechnology companies.

By membrane pore size, the market is divided into 0.22, 0.45 & 0.1 microns. Of these, the 0.22 microns accounted for the largest growing segment in the global sterile filtration market by 2020. On the basis of applications, the sterile filtration market is categorized into bioprocesses, fill-finish process, utilities filtration, pre-filtration, and virus filtration.


The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). Geographic analysis reveals that North America accounted for the largest share of the global sterile filtration market in 2015. Growth in this market can be attributed to the growth of biopharmaceutical industry and increase in R&D spending.

The major players in this market include Merck KGaA (Germany), General Electric Company (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech Group (France), Sigma Aldrich Corporation (U.S.), 3M (U.S.), Porvair Filtration Group (U.K.), Starlabs Scientific (U.S.), and Sterlitech Corporation (U.S.)



About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Article Credit: Healthcare DC
Labels:

Comments

Post a Comment

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...
Post a Comment
Read more

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...
Post a Comment
Read more

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...
Post a Comment
Read more